Case Reports
doi: 10.1177/106002808501900707.
Amoxapine-induced tardive dyskinesia
- PMID: 4028958
- DOI: 10.1177/106002808501900707
Item in Clipboard
Case Reports
Amoxapine-induced tardive dyskinesia
Drug Intell Clin Pharm.
1985 Jul-Aug.
Abstract
A case report of amoxapine-induced tardive dyskinesia following discontinuation of amoxapine therapy is reported. During 68 weeks of therapy, the patient received a maximum of amoxapine 400 mg/d. Six months after amoxapine discontinuation, the patient continued to have symptoms of tardive dyskinesia. These symptoms correlate with the dopamine receptor-blocking property of amoxapine and its metabolites. We propose that amoxapine therapy be monitored for the long-term as well as the short-term adverse effects of dopamine receptor-blockade.
Similar articles
-
Case report of withdrawal dyskinesia associated with amoxapine.Am J Psychiatry. 1983 Oct;140(10):1358-9. doi: 10.1176/ajp.140.10.1358. Am J Psychiatry. 1983. PMID: 6624971
-
Persistent tardive dyskinesia associated with amoxapine therapy--two case reports.Hillside J Clin Psychiatry. 1986;8(2):209-13. Hillside J Clin Psychiatry. 1986. PMID: 3557296
-
Case report of withdrawal dyskinesia associated with amoxapine.Am J Psychiatry. 1983 Nov;140(11):1515-6. doi: 10.1176/ajp.140.11.1515. Am J Psychiatry. 1983. PMID: 6625005
-
[A case of amoxapine-induced tardive dystonia successfully treated with a low dose anti-cholinergic agent].Rinsho Shinkeigaku. 2000 Apr;40(4):367-71. Rinsho Shinkeigaku. 2000. PMID: 10967655 Review. Japanese.
-
The treatment of tardive dyskinesia.Schweiz Arch Neurol Psychiatr (1985). 1996;147(1):13-8. Schweiz Arch Neurol Psychiatr (1985). 1996. PMID: 8685689 Review.
Cited by
-
Amoxapine-induced tardive dyskinesia.Indian J Psychiatry. 2009 Oct-Dec;51(4):327. doi: 10.4103/0019-5545.58305. Indian J Psychiatry. 2009. PMID: 20048464 Free PMC article. No abstract available.
-
Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs.Drugs. 1989 May;37(5):713-38. doi: 10.2165/00003495-198937050-00006. Drugs. 1989. PMID: 2663417 Review.
-
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database.BMC Psychiatry. 2020 Jun 16;20(1):308. doi: 10.1186/s12888-020-02711-z. BMC Psychiatry. 2020. PMID: 32546134 Free PMC article.